Skip to main content
Top
Published in: Sleep and Breathing 3/2017

01-09-2017 | Neurology • Original Article

Hypoxia and inflammation indicate significant differences in the severity of obstructive sleep apnea within similar apnea-hypopnea index groups

Authors: Aynur Yilmaz Avci, Suat Avci, Huseyin Lakadamyali, Ufuk Can

Published in: Sleep and Breathing | Issue 3/2017

Login to get access

Abstract

Purpose

We determined whether hypoxia parameters are associated with C-reactive protein (CRP), mean platelet volume (MPV), white matter hyperintensity (WMH), and the severity of obstructive sleep apnea (OSA), and also evaluated whether hypoxia parameters, CRP, MPV, and WMH differ in patients with similar apnea-hypopnea index (AHI) scores.

Methods

A total of 297 patients, who were evaluated using polysomnography, were assessed retrospectively. The measured hypoxia parameters included total sleep time with oxygen saturation <90% (ST90), percentage of cumulative time with oxygen saturation <90% (CT90), and lowest oxygen saturation (min SaO2). The patients were divided into subgroups according to their CT90 values, and patients with different AHI severities were divided into subgroups according to their ST90 and min SaO2 levels.

Results

Hypoxia parameters are associated with CRP, MPV, WMH, and the severity of OSA (P < 0.05). The hypoxia parameters differed in all subgroup analyses of similar AHI groups (P < 0.001), and CRP differed only in severe OSA (P < 0.008, P < 0.001). In subgroup analyses of similar AHI groups, MPV and WMH were not significantly different (P > 0.05). Above the hypoxia threshold (CT90 ≥ 10%) of CRP, MPV increased significantly and the presence of WMH increased twofold.

Conclusions

These data suggest that increased hypoxia severity may mediate increased inflammation and activation of platelets and contribute to the pathogenesis of WMH in patients with OSA. In addition, patients with severe OSA may show significant variability in inflammation and vascular risk. Further prospective data are needed.
Literature
1.
go back to reference Berry RB, Brooks R, Gamaldo CE, Harding SM, Lloyd RM, Marcus CL, Vaughn BV, American Academy of Sleep Medicine (2015) The AASM manual for the scoring of sleep and associated events: rules, terminology and technical specifications, version 2.2. Darien IL: American Academy of sleep medicine. J Clin Sleep Med 15(11):1253–1254CrossRef Berry RB, Brooks R, Gamaldo CE, Harding SM, Lloyd RM, Marcus CL, Vaughn BV, American Academy of Sleep Medicine (2015) The AASM manual for the scoring of sleep and associated events: rules, terminology and technical specifications, version 2.2. Darien IL: American Academy of sleep medicine. J Clin Sleep Med 15(11):1253–1254CrossRef
2.
go back to reference Zhang XB, Zen HQ, Lin QC, Chen GP, Chen LD, Chen H (2014a) TST, as a polysomnographic variable, is superior to the apnea hypopnea index for evaluating intermittent hypoxia in severe obstructive sleep apnea. Eur Arch Otorhinolaryngol. doi:10.1007/s00405-014-3044-0 PubMedCentral Zhang XB, Zen HQ, Lin QC, Chen GP, Chen LD, Chen H (2014a) TST, as a polysomnographic variable, is superior to the apnea hypopnea index for evaluating intermittent hypoxia in severe obstructive sleep apnea. Eur Arch Otorhinolaryngol. doi:10.​1007/​s00405-014-3044-0 PubMedCentral
3.
go back to reference Kulkas A, Tiihonen P, Julkunen P, Mervaala E, Töyräs J (2013) Novel parameters indicate significant differences in severity of obstructive sleep apnea with patients having similar apnea-hypopnea index. Med Biol Eng Comput. doi:10.1007/s11517-013-1039-4 PubMed Kulkas A, Tiihonen P, Julkunen P, Mervaala E, Töyräs J (2013) Novel parameters indicate significant differences in severity of obstructive sleep apnea with patients having similar apnea-hypopnea index. Med Biol Eng Comput. doi:10.​1007/​s11517-013-1039-4 PubMed
4.
5.
go back to reference Somers VK, White DP, Amin R, Abraham WT, Costa F, Culebras A et al (2008) Sleep apnea and cardiovascular disease: an American Heart Association/American College Of Cardiology Foundation scientific statement from the American Heart Association Council for high blood pressure research professional education committee, council on clinical cardiology, stroke council, and council on cardiovascular nursing. In collaboration with the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health). Circulation. doi:10.1161/CIRCULATIONAHA.107.189375 PubMed Somers VK, White DP, Amin R, Abraham WT, Costa F, Culebras A et al (2008) Sleep apnea and cardiovascular disease: an American Heart Association/American College Of Cardiology Foundation scientific statement from the American Heart Association Council for high blood pressure research professional education committee, council on clinical cardiology, stroke council, and council on cardiovascular nursing. In collaboration with the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health). Circulation. doi:10.​1161/​CIRCULATIONAHA.​107.​189375 PubMed
7.
go back to reference Ridker PM (2007) C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: moving an inflammatory hypothesis toward consensus. J Am Coll Cardiol 49(21):2129–2138CrossRefPubMed Ridker PM (2007) C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: moving an inflammatory hypothesis toward consensus. J Am Coll Cardiol 49(21):2129–2138CrossRefPubMed
8.
go back to reference Muraki I, Tanigawa T, Yamagishi K, Sakurai S, Ohira T, Imano H et al (2010) Nocturnal intermittent hypoxia and C reactive protein among middle-aged community residents: a cross-sectional survey. Thorax. doi:10.1136/thx.2009.128744 PubMed Muraki I, Tanigawa T, Yamagishi K, Sakurai S, Ohira T, Imano H et al (2010) Nocturnal intermittent hypoxia and C reactive protein among middle-aged community residents: a cross-sectional survey. Thorax. doi:10.​1136/​thx.​2009.​128744 PubMed
9.
go back to reference Rahangdale S, Yeh SY, Novack V, Stevenson K, Barnard MR, Furman MI, Frelinger AL, Michelson AD, Malhotra A (2011) The influence of intermittent hypoxemia on platelet activation in obese patients with obstructive sleep apnea. J Clin Sleep Med 7(2):172–178PubMedPubMedCentral Rahangdale S, Yeh SY, Novack V, Stevenson K, Barnard MR, Furman MI, Frelinger AL, Michelson AD, Malhotra A (2011) The influence of intermittent hypoxemia on platelet activation in obese patients with obstructive sleep apnea. J Clin Sleep Med 7(2):172–178PubMedPubMedCentral
10.
go back to reference Tsiara S, Elisaf M, Jagroop IA, Mikhailidis DP (2009) Platelets as predictors of vascular risk: is there a practical index of platelet activity? Clin Appl Thromb Hemost 9(3):177–190CrossRef Tsiara S, Elisaf M, Jagroop IA, Mikhailidis DP (2009) Platelets as predictors of vascular risk: is there a practical index of platelet activity? Clin Appl Thromb Hemost 9(3):177–190CrossRef
11.
go back to reference Martin JF, Shaw T, Heggie J, Penington DG (1983) Measurement of the density of human platelets and its relationship to volume. Br J Haematol 54(3):337–352CrossRefPubMed Martin JF, Shaw T, Heggie J, Penington DG (1983) Measurement of the density of human platelets and its relationship to volume. Br J Haematol 54(3):337–352CrossRefPubMed
13.
go back to reference Nena E, Papanas N, Steiropoulos P, Zikidou P, Zarogoulidis P, Pita E et al (2012) Mean platelet volume and platelet distribution width in non-diabetic subjects with obstructive sleep apnoea syndrome: new indices of severity? Platelets. doi:10.3109/09537104.2011.632031 PubMed Nena E, Papanas N, Steiropoulos P, Zikidou P, Zarogoulidis P, Pita E et al (2012) Mean platelet volume and platelet distribution width in non-diabetic subjects with obstructive sleep apnoea syndrome: new indices of severity? Platelets. doi:10.​3109/​09537104.​2011.​632031 PubMed
14.
go back to reference Ovbiagele B, Saver JL (2006) Cerebral white matter hyperintensities on MRI: current concepts and therapeutic implications. Cerebrovasc Dis 22(2–3):83–90CrossRefPubMed Ovbiagele B, Saver JL (2006) Cerebral white matter hyperintensities on MRI: current concepts and therapeutic implications. Cerebrovasc Dis 22(2–3):83–90CrossRefPubMed
15.
go back to reference Fazekas F, Kleinert R, Offenbacher H, Schmidt R, Kleinert G, Payer F et al (1993) Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology 43(9):1683–1689CrossRefPubMed Fazekas F, Kleinert R, Offenbacher H, Schmidt R, Kleinert G, Payer F et al (1993) Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology 43(9):1683–1689CrossRefPubMed
17.
go back to reference Kim H, Yun CH, Thomas RJ, Lee SH, Seo HS, Cho ER et al (2013) Obstructive sleep apnea as a risk factor for cerebral white matter change in middle-aged and older general population. Sleep. doi:10.5665/sleep.2632 Kim H, Yun CH, Thomas RJ, Lee SH, Seo HS, Cho ER et al (2013) Obstructive sleep apnea as a risk factor for cerebral white matter change in middle-aged and older general population. Sleep. doi:10.​5665/​sleep.​2632
18.
go back to reference Nishibayashi M, Miyomoto M, Miyamoto T, Suzuki K, Hirata K (2008) Correlation between severity of obstructive sleep apnea and prevalence of silent cerebrovascular lesions. J Clin Sleep Med 4(3):242–247PubMedPubMedCentral Nishibayashi M, Miyomoto M, Miyamoto T, Suzuki K, Hirata K (2008) Correlation between severity of obstructive sleep apnea and prevalence of silent cerebrovascular lesions. J Clin Sleep Med 4(3):242–247PubMedPubMedCentral
19.
20.
go back to reference Guilleminault C, Kirisoglu C, Ohayon MM (2004) C-reactive protein and sleep-disordered breathing. Sleep 27(8):1507–1511CrossRefPubMed Guilleminault C, Kirisoglu C, Ohayon MM (2004) C-reactive protein and sleep-disordered breathing. Sleep 27(8):1507–1511CrossRefPubMed
21.
go back to reference Taheri S, Austin D, Lin L, Nieto FJ, Young T, Mignot E (2007) Correlates of serum C-reactive protein (CRP)–no association with sleep duration or disordered breathing. Sleep 30(8):991–996CrossRefPubMedPubMedCentral Taheri S, Austin D, Lin L, Nieto FJ, Young T, Mignot E (2007) Correlates of serum C-reactive protein (CRP)–no association with sleep duration or disordered breathing. Sleep 30(8):991–996CrossRefPubMedPubMedCentral
24.
go back to reference Davies CW, Crosby JH, Mullins RL, Traill ZC, Anslow P, Davies RJ et al (2001) Case control study of cerebrovascular damage defined by magnetic resonance imaging in patients with OSA and normal matched control subjects. Sleep 24(6):715–720CrossRefPubMed Davies CW, Crosby JH, Mullins RL, Traill ZC, Anslow P, Davies RJ et al (2001) Case control study of cerebrovascular damage defined by magnetic resonance imaging in patients with OSA and normal matched control subjects. Sleep 24(6):715–720CrossRefPubMed
25.
go back to reference Ding J, Nieto FJ, Beauchamp NJ Jr, Harris TB, Robbins JA, Hetmanski JB et al (2004) Sleep-disordered breathing and white matter disease in the brainstem in older adults. Sleep 27(3):474–479CrossRefPubMed Ding J, Nieto FJ, Beauchamp NJ Jr, Harris TB, Robbins JA, Hetmanski JB et al (2004) Sleep-disordered breathing and white matter disease in the brainstem in older adults. Sleep 27(3):474–479CrossRefPubMed
26.
go back to reference Wakita H, Tomimoto H, Akiguchi I, Matsuo A, Lin JX, Ihara M et al (2002) Axonal damage and demyelination in the white matter after chronic cerebral hypoperfusion in the rat. Brain Res 924(1):63–70CrossRefPubMed Wakita H, Tomimoto H, Akiguchi I, Matsuo A, Lin JX, Ihara M et al (2002) Axonal damage and demyelination in the white matter after chronic cerebral hypoperfusion in the rat. Brain Res 924(1):63–70CrossRefPubMed
27.
go back to reference Turhan M, Bostanci A, Bozkurt S (2015) Predicting the outcome of modified tongue base suspension combined with uvulopalatopharyngoplasty. Eur Arch Otorhinolaryngol. doi:10.1007/s00405-014-3311-0 Turhan M, Bostanci A, Bozkurt S (2015) Predicting the outcome of modified tongue base suspension combined with uvulopalatopharyngoplasty. Eur Arch Otorhinolaryngol. doi:10.​1007/​s00405-014-3311-0
29.
go back to reference Kimoff RJ, Sforza E, Champagne V, Ofiara L, Gendron D (2001) Upper airway sensation in snoring and obstructive sleep apnea. Am J Respir Crit Care Med 164(2):250–255CrossRefPubMed Kimoff RJ, Sforza E, Champagne V, Ofiara L, Gendron D (2001) Upper airway sensation in snoring and obstructive sleep apnea. Am J Respir Crit Care Med 164(2):250–255CrossRefPubMed
30.
go back to reference Bradford A, McGuire M, O'Halloran KD (2005) Does episodic hypoxia affect upper airway dilator muscle function? Implications for the pathophysiology of obstructive sleep apnoea. Respir Physiol Neurobiol. doi:10.1016/j.resp.2005.04.001 Bradford A, McGuire M, O'Halloran KD (2005) Does episodic hypoxia affect upper airway dilator muscle function? Implications for the pathophysiology of obstructive sleep apnoea. Respir Physiol Neurobiol. doi:10.​1016/​j.​resp.​2005.​04.​001
Metadata
Title
Hypoxia and inflammation indicate significant differences in the severity of obstructive sleep apnea within similar apnea-hypopnea index groups
Authors
Aynur Yilmaz Avci
Suat Avci
Huseyin Lakadamyali
Ufuk Can
Publication date
01-09-2017
Publisher
Springer International Publishing
Published in
Sleep and Breathing / Issue 3/2017
Print ISSN: 1520-9512
Electronic ISSN: 1522-1709
DOI
https://doi.org/10.1007/s11325-017-1486-5

Other articles of this Issue 3/2017

Sleep and Breathing 3/2017 Go to the issue

Sleep Breathing Physiology and Disorders • Short Communication

Central sleep apnea in multiple sclerosis: a pilot study

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.